Full text
PDFPage 1504
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Cuckle H., Lilford R. Antenatal screening for Down's syndrome. BMJ. 1992 Oct 24;305(6860):1017–1017. doi: 10.1136/bmj.305.6860.1017. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mutton D. E., Alberman E., Ide R., Bobrow M. Results of first year (1989) of a national register of Down's syndrome in England and Wales. BMJ. 1991 Nov 23;303(6813):1295–1297. doi: 10.1136/bmj.303.6813.1295. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Nicolaides K. H., Azar G., Byrne D., Mansur C., Marks K. Fetal nuchal translucency: ultrasound screening for chromosomal defects in first trimester of pregnancy. BMJ. 1992 Apr 4;304(6831):867–869. doi: 10.1136/bmj.304.6831.867. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Schulte-Vallentin M., Schindler H. Non-echogenic nuchal oedema as a marker in trisomy 21 screening. Lancet. 1992 Apr 25;339(8800):1053–1053. doi: 10.1016/0140-6736(92)90574-m. [DOI] [PubMed] [Google Scholar]
- Wald N., Wald K., Smith D. The extent of Down's syndrome screening in Britain in 1991. Lancet. 1992 Aug 22;340(8817):494–494. doi: 10.1016/0140-6736(92)91822-p. [DOI] [PubMed] [Google Scholar]
- van Zalen-Sprock M. M., van Vugt J. M., van Geijn H. P. Non-echogenic nuchal oedema as a marker in trisomy 21 screening. Lancet. 1992 Jun 13;339(8807):1480–1481. doi: 10.1016/0140-6736(92)92074-p. [DOI] [PubMed] [Google Scholar]